» Articles » PMID: 1689742

The N- and C-terminal Boundaries of Myelin Basic Protein Determinants Required for Encephalitogenic and Proliferative Responses of Lewis Rat T Cells

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 1990 Mar 1
PMID 1689742
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Highly purified synthetic peptides representing portions of the 68-86 sequence of guinea pig (GP) myelin basic protein (GPMBP) were used to define the N- and C-termini of encephalitogenic determinants that cause experimental autoimmune encephalomyelitis (EAE) in Lewis rats. Each peptide was tested for: (a) induction of EAE, (b)in vitro potentiation of EAE transfer activity by GPMBP-sensitized lymph node cells (LNC), (c) in vitro proliferation of GPMBP-sensitized LNC, and (d) in vitro proliferation of a GPMBP-reactive line of EAE-inducing T cells. In these bioassays, the general rank order of potency was: GPMBP greater than or equal to GP68-86 greater than or equal to GP72-86 greater than [G84]GP68-86 greater than or equal to GP68-84 much greater than GP75-85 greater than or equal to GP75-84 = virtually no activity. These results demonstrate that the encephalitogenic region is bounded by the 72-74 and 84-86 sequences. Further evidence presented herein indicates that the 75-84 sequence contains the primary antigenic features required for specific T cell recognition of the encephalitogenic region.

Citing Articles

The extracellular domain of myelin oligodendrocyte glycoprotein elicits atypical experimental autoimmune encephalomyelitis in rat and Macaque species.

Curtis 2nd A, Taslim N, Reece S, Grebenciucova E, Ray R, Rosenbaum M PLoS One. 2014; 9(10):e110048.

PMID: 25303101 PMC: 4193844. DOI: 10.1371/journal.pone.0110048.


Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).

Abbott D, Blanchfield J, Martinson D, Russell S, Taslim N, Curtis A BMC Immunol. 2012; 12:72.

PMID: 22208499 PMC: 3261124. DOI: 10.1186/1471-2172-12-72.